Pharmafile Logo
Pharmafocus logo
Advanced Search
UK swine flu leaflet

UK swine flu cases fall

February 5, 2010
Sales and Marketing h1n1, swine flu

The government has warned against complacency over swine flu as it released figures showing UK cases had fallen to one …

News

GSK looks to rare diseases research

February 5, 2010
Research and Development GlaxoSmithKline, Orphan

GlaxoSmithKline has launched a new specialist unit to research and develop medicines for rare diseases. The company has identified 5,500 …

News
Cohn and Wolfe Mike Kan

Cohn & Wolfe appoints Mike Kan

February 5, 2010
Medical Communications Cohn & Wolfe, appointment, medical communications

Cohn & Wolfe has appointed Mike Kan as global healthcare practice leader. He assumes the role from Linda Dyson who …

Appointment

Recipharm charms Cobra shareholders into selling up

February 5, 2010
Manufacturing and Production Cobra, Recipharm, Wasserburger

Swedish contract development and manufacturing organisation (CDMO) Recipharm has said that its takeover bid for UK company Cobra Biomanufacturing has …

News
ABPI

Barker praises OLS model

February 5, 2010
Research and Development, Sales and Marketing ABPI, Blueprint, OLS

The ABPI’s director general spoke to Pharmafocus about the promise of the new Blueprint at its launch in London last …

News
Andrew Witty

GSK confirms job cuts but avoids specifics

February 5, 2010
Research and Development, Sales and Marketing 2009 financials, GlaxoSmithKline

GlaxoSmithKline has sidestepped questions about the internal fall-out from its new plan to slash R&D infrastructure costs. Presenting the company’s …

News
Photo_Miguel_Forte300dpi

Miguel Forte joins TxCell

February 5, 2010
Research and Development TxCell, appointment, research and development

French biotech TxCell has appointed Miguel Forte to fill its newly-created role of chief medical officer. Miguel joins the company …

Appointment

Portfolio Harmony in five easy steps

February 5, 2010
Sales and Marketing product portfolio

Portfolio planning should be a practical process that delivers a programme of work to take you to sunnier shores. All …

Feature

Zeftera problems weigh down Basilea

February 5, 2010
Sales and Marketing 2009 financials, Basilea, Zeftera

Specialist Swiss pharma company Basilea has announced a doubling of its revenues in 2009, thanks to the launch of its …

News

GSK acquires respiratory candidate

February 4, 2010
Research and Development Apeiron, GlaxoSmithKline, respiratory

GlaxoSmithKline has acquired exclusive rights to a biotherapeutic enzyme developed for use against Acute Respiratory Distress Syndrome (ARDS). The move …

News
Pfizer World

Wyeth acquisition yet to shake Pfizer’s Lipitor dependence

February 4, 2010
Sales and Marketing 2009 financials, Lipitor, Pfizer

Pfizer’s profits rose by 7% last year on the back of a 4% increase in revenue driven by cholesterol treatment …

News

Fishawack makes US acquisition

February 4, 2010
Medical Communications Nexus Communications, fishawack

Cheshire-based healthcare agency Fishawack Communications has bought US outfit Nexus Communications. The company says this acquisition is part of a …

News

Oxford Immunotec appoints Frank Vandeputte

February 4, 2010
Sales and Marketing Oxford Immunotec, appointment, medical devices, sales and marketing

Medical diagnostics company Oxford Immunotec has appointed Frank Vandeputte vice president, sales and marketing. He was formerly VP, Europe for …

Appointment

Eden Biodesign passes into Watson Pharma’s hands

February 4, 2010
Manufacturing and Production Eden Biodesign, Watson Pharma, biologicals

UK biologics manufacturing specialist Eden Biodesign has been bought by US drugmaker Watson Pharmaceuticals in a $15 million deal. The …

News

Lancet retracts MMR research conclusions

February 3, 2010
Research and Development MMR, Sanofi, vaccines

The Lancet, the journal which originally published the controversial research linking the MMR vaccine to autism has issued a full …

News

Digital Pharma: New EMA website previewed

February 3, 2010
Research and Development, Sales and Marketing EMA, branding, digital pharma

The European Medicines Agency is preparing to overhaul its website to make it easier for users to get information. This …

News

Digital added to PM’s as Langland clean up

February 3, 2010
Medical Communications Langland, awards, pm society

Langland swept the board at the PM Society’s Advertising Awards on 29 January with seven wins across 20 award categories. …

News

FDA to assess Neupogen biosimilar

February 3, 2010
Research and Development, Sales and Marketing Hospira, Teva, biosimilars

US regulator the FDA has agreed to assess Teva’s application for a biosimilar version of Amgen’s Neupogen (filgrastim). XM02, a …

News
Roche building

Genentech integration hits Roche profits

February 3, 2010
Sales and Marketing 2009 financials, Genentech, Roche

Roche achieved healthy sales growth in 2009 but saw a 22% drop in net income due to the cost gaining …

News

Talking Careers: The brief has changed

February 2, 2010
Business Services Talking Point, interim management, rsa, talking careers

Planning for the future is crucial at any time, but particularly when the market has changed and contracted as the …

Feature
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025